It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mammalian DNA methylation patterns are established by two de novo DNA methyltransferases, DNMT3A and DNMT3B, which exhibit both redundant and distinctive methylation activities. However, the related molecular basis remains undetermined. Through comprehensive structural, enzymology and cellular characterization of DNMT3A and DNMT3B, we here report a multi-layered substrate-recognition mechanism underpinning their divergent genomic methylation activities. A hydrogen bond in the catalytic loop of DNMT3B causes a lower CpG specificity than DNMT3A, while the interplay of target recognition domain and homodimeric interface fine-tunes the distinct target selection between the two enzymes, with Lysine 777 of DNMT3B acting as a unique sensor of the +1 flanking base. The divergent substrate preference between DNMT3A and DNMT3B provides an explanation for site-specific epigenomic alterations seen in ICF syndrome with DNMT3B mutations. Together, this study reveals distinctive substrate-readout mechanisms of the two DNMT3 enzymes, implicative of their differential roles during development and pathogenesis.
In mammals, DNA methylation patterns are established by two de novo DNA methyltransferases, DNMT3A and DNMT3B. Here the authors report the crystal structures of DNMT3B in complex with both CpG and CpA DNA, providing insight into the substrate-recognition mechanism underpinning the divergent genomic methylation activities of DNMT3A and DNMT3B.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 University of California, Environmental Toxicology Graduate Program, Riverside, USA (GRID:grid.266097.c) (ISNI:0000 0001 2222 1582)
2 University of Stuttgart, Department of Biochemistry, Institute of Biochemistry and Technical Biochemistry, Stuttgart, Germany (GRID:grid.5719.a) (ISNI:0000 0004 1936 9713)
3 University of North Carolina at Chapel Hill School of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208); University of North Carolina at Chapel Hill, Curriculum in Genetics and Molecular Biology, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208)
4 National Institute of Environmental Health Sciences, Division of Intramural Research, Epigenetics and Stem Cell Biology Laboratory, Durham, USA (GRID:grid.280664.e) (ISNI:0000 0001 2110 5790)
5 University of California, Department of Biochemistry, Riverside, USA (GRID:grid.266097.c) (ISNI:0000 0001 2222 1582)
6 University of North Carolina at Chapel Hill School of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208)
7 University of California, Department of Biochemistry, Riverside, USA (GRID:grid.266097.c) (ISNI:0000 0001 2222 1582); Jinan University, School of Pharmacy, Guangzhou, China (GRID:grid.258164.c) (ISNI:0000 0004 1790 3548)
8 University of North Carolina at Chapel Hill School of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208); University of North Carolina at Chapel Hill, Department of Biochemistry and Biophysics, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208)
9 University of Stuttgart, Department of Biochemistry, Institute of Biochemistry and Technical Biochemistry, Stuttgart, Germany (GRID:grid.5719.a) (ISNI:0000 0004 1936 9713); Cardiff University, School of Biosciences, Cardiff, UK (GRID:grid.5600.3) (ISNI:0000 0001 0807 5670)
10 University of California, Environmental Toxicology Graduate Program, Riverside, USA (GRID:grid.266097.c) (ISNI:0000 0001 2222 1582); University of California, Department of Chemistry, Riverside, USA (GRID:grid.266097.c) (ISNI:0000 0001 2222 1582)
11 University of North Carolina at Chapel Hill School of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208); University of North Carolina at Chapel Hill, Curriculum in Genetics and Molecular Biology, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208); University of North Carolina at Chapel Hill, Department of Biochemistry and Biophysics, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208)
12 University of California, Environmental Toxicology Graduate Program, Riverside, USA (GRID:grid.266097.c) (ISNI:0000 0001 2222 1582); University of California, Department of Biochemistry, Riverside, USA (GRID:grid.266097.c) (ISNI:0000 0001 2222 1582)